US Drug Registration Compliance: FDA Registration & Drug Listing Guide

Us drug registration online, Fda us drug registration, Us drug registration lookup, Us drug registration requirements, Us drug registration form, FDA Registration Login, FDA Food Facility Registration search, FDA Registration Online, What is US FDA registration?, What is the difference between FDA and USFDA?, How to check US FDA registration?, What is FDA and MHRA?, What is FDA called in India?, What is 21 CFR full form?, Is FDA valid in India?, What are the 5 categories of FDA?, What is Category 1 and 2 MHRA?

Pharmaceutical companies planning to enter or operate in the United States must comply with US Drug Registration requirements. This regulatory process is administered by the U.S. Food and Drug Administration (FDA) and is mandatory for both domestic and international drug manufacturers.

FDA drug registration ensures that manufacturing facilities and drug products are properly recorded with the agency before commercial distribution or import into the US market.

What Does US Drug Registration Mean?

US Drug Registration is a statutory requirement under the Federal Food, Drug, and Cosmetic Act (FD&C Act). It obligates companies to formally notify the FDA about:

Drug manufacturing establishments
Drug products intended for the US market

The process consists of two independent but connected obligations:

Drug Establishment Registration
FDA Drug Product Listing

Completion of both steps is required to remain legally compliant.

It is essential to understand that FDA registration does not indicate FDA approval. Approval applies only to specific drug categories and involves a separate regulatory pathway.

Companies Required to Register with the FDA

FDA drug registration applies to a wide range of pharmaceutical entities, including:

Prescription drug manufacturers
Over-the-counter (OTC) drug manufacturers
Contract manufacturing organizations
Repackers and relabelers
Foreign drug manufacturers exporting to the US

Foreign establishments must also appoint a US Agent, who acts as the FDA’s official liaison for communication and inspection coordination.

Drug Establishment Registration Explained

Each facility involved in drug manufacturing, processing, or packaging must be registered separately with the FDA.

Key Registration Requirements

Registration is mandatory and renewed annually
Renewal period runs from October 1 to December 31
Required prior to FDA inspections and importation
Applies to US and non-US facilities

Failure to renew establishment registration may lead to inactive status, shipment delays, or import refusal at US ports.

FDA Drug Listing Requirements

Once an establishment is registered, every drug product must be listed with the FDA.

Drug listing submissions include detailed product data such as:

Brand and generic drug names
Dosage form and strength
Route of administration
Labeler information
National Drug Code (NDC)
Product labeling details

All listings are submitted electronically using the FDA’s Structured Product Labeling (SPL) system. Accurate alignment between SPL data and product labels is critical to avoid rejection or correction requests.

National Drug Code (NDC) and Its Role

The National Drug Code (NDC) is a unique identifier assigned to drug products listed with the FDA. While the FDA does not approve NDCs, correct NDC configuration is essential for:

Commercial distribution in the US
Pharmacy and hospital databases
Insurance reimbursement processes
Import and export documentation

Incorrect NDC assignment is a common cause of FDA listing compliance issues.

FDA Registration for Foreign Drug Manufacturers

Foreign drug manufacturers face additional regulatory responsibilities, including:

Appointment and maintenance of a US Agent
Import compliance coordination
FDA inspection readiness outside the US
Consistency between listing data and shipping documents

Any mismatch in registration or listing details can trigger import alerts or regulatory scrutiny.

Common FDA Drug Registration Issues

Companies frequently encounter compliance challenges such as:

Incorrect SPL preparation
Labeling inconsistencies
Missed annual renewals
Inaccurate US Agent information
Confusion between FDA registration and product approval

These issues can delay product launches and disrupt supply chains.

Professional Support for FDA Drug Registration

Managing FDA drug registration requires regulatory expertise, technical accuracy, and continuous compliance monitoring. Even minor errors can result in costly delays or enforcement actions.

XPRO America, a US FDA Consultancy, offers comprehensive FDA drug registration and listing services for pharmaceutical companies worldwide. Their regulatory team supports establishment registration, drug listing submissions, SPL preparation, NDC setup, US Agent services, and annual renewal management.

For organizations seeking reliable and compliant FDA registration support, regulatory specialists at XPRO America can be reached at support@xproamerica.com to discuss specific product and market requirements.

Conclusion

US Drug Registration is a critical regulatory foundation for accessing and maintaining presence in the US pharmaceutical market. While administrative in nature, it requires precision, regulatory knowledge, and ongoing maintenance.

By ensuring accurate FDA establishment registration and drug listing—and partnering with an experienced US FDA consultancy—companies can reduce compliance risks, avoid unnecessary delays, and focus on long-term growth in the United States.